Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease
Muanda FT, Blake PG, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Urquhart BL, Kim RB, Garg AX. JAMA Netw Open. 2023; 6(11):e2345132. Epub 2023 Nov 27.
Background — Renal insufficiency is highly prevalent in North America and has been established as a nontraditional risk factor for cardiovascular disease. Cardiovascular disease remains the primary cause of mortality in the general population and is often treated with coronary artery bypass surgery (CABG). This population-based study aimed to determine the risk of nondialysis dependent renal insufficiency (RI) on the long-term outcomes of patients who undergo CABG.
Methods — Prospectively collected data from 26,506 patients were abstracted from the Cardiac Care Network database from 9 revascularization hospitals in Ontario, Canada. Multivariate regression analysis examined associations between preoperative RI and inhospital, 30-day, and 1-year mortality according to 3 levels of serum creatinine: <120 μmol/L (normal), 120 to 180 μmol/L (mild RI), and >180 μmil/L (moderate-severe RI) and 5 levels of creatinine clearance (Cockcroft-Gault): >100 mL/min (normal), 80 to 99 mL/min (mild impairment), 60 to 79 mL/min (mild-moderate impairment), 40 to 59 mL/min (moderate impairment), and <40 mL/min (severe impairment).
Results — The overall inhospital, 30-day, and 1-year mortality rates were 1.90%, 2.0%, and 4.5%, respectively. Patients with RI had greater overall comorbidity. After adjustment for confounding factors, RI was associated with the greater risk of both 30-day (odds ratio 3.7, 95% CI 2.3–5.8, P < .0001) and 1-year mortality (odds ratio 4.6, 95% CI 3.3–6.4, P < .0001).
Conclusion — Preoperative renal impairment should be recognized as a significant risk factor for mortality after CABG. A trend of increasing risk with severity of renal impairment was demonstrated for both 30-day and 1-year mortality in this large, population-based study.
Lok CE, Austin PC, Wang H, Tu JV. Am Heart J. 2004; 148(3):430-8.
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.